MA41812A - Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc - Google Patents

Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Info

Publication number
MA41812A
MA41812A MA041812A MA41812A MA41812A MA 41812 A MA41812 A MA 41812A MA 041812 A MA041812 A MA 041812A MA 41812 A MA41812 A MA 41812A MA 41812 A MA41812 A MA 41812A
Authority
MA
Morocco
Prior art keywords
intermediaries
hcv
preparation
methods
protease inhibitor
Prior art date
Application number
MA041812A
Other languages
English (en)
Inventor
Maude Brossat
Dominique Paul Michel Depré
Sébastien Nicolas J Hermant
Andras Horvath
Sébastien François Emmanuel LEMAIRE
Thomas Shaw Moody
Dominic John Ormerod
Olivier Riant
Nicolas Vriamont
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of MA41812A publication Critical patent/MA41812A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26—Ketones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/61—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA041812A 2015-03-27 2016-03-24 Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc MA41812A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15161431 2015-03-27

Publications (1)

Publication Number Publication Date
MA41812A true MA41812A (fr) 2018-01-30

Family

ID=52737010

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041812A MA41812A (fr) 2015-03-27 2016-03-24 Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Country Status (15)

Country Link
US (1) US20180093943A1 (fr)
EP (1) EP3274324A1 (fr)
JP (1) JP2018517661A (fr)
KR (1) KR20170131449A (fr)
CN (1) CN107429270A (fr)
AU (1) AU2016241924A1 (fr)
BR (1) BR112017019898A2 (fr)
CA (1) CA2976175A1 (fr)
EA (1) EA201792114A1 (fr)
HK (1) HK1247246A1 (fr)
IL (1) IL253899A0 (fr)
MA (1) MA41812A (fr)
MX (1) MX2017012348A (fr)
SG (1) SG11201707594SA (fr)
WO (1) WO2016157058A1 (fr)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
JO2768B1 (en) * 2005-07-29 2014-03-15 تيبوتيك فارماسيوتيكالز ليمتد Large cyclic inhibitors of hepatitis C virus
RU2483067C2 (ru) 2007-02-01 2013-05-27 Тиботек Фармасьютикалз Лтд. Способы и промежуточные продукты для получения макроциклического ингибитора протеазы вируса гепатита с
WO2009142842A2 (fr) 2008-04-15 2009-11-26 Intermune, Inc. Nouveaux inhibiteurs macrocycliques de la réplication du virus de l’hépatite c
DK2382198T3 (da) 2008-12-23 2013-09-30 Janssen Pharmaceuticals Inc Fremgangsmåder og mellemprodukter til fremstilling af en makrocyklisk inhibitor af hcv-protease
EP2547645B1 (fr) 2010-03-16 2018-07-04 Janssen Pharmaceuticals, Inc. Verfahren und zwischenprodukte zur herstellung eines makrozyklischen proteasehemmers von hcv
EA201490254A1 (ru) * 2011-08-24 2014-07-30 ГЛАКСОСМИТКЛАЙН ЭлЭлСи Комбинированное лечение гепатита с
TWI565704B (zh) 2011-09-22 2017-01-11 健生醫藥公司 用於製備hcv巨環蛋白酶抑制劑之方法及中間物
JP6231482B2 (ja) 2011-10-28 2017-11-15 ヤンセン ファーマシューティカルズ,インコーポレーテッド 大環状プロテアーゼ阻害剤tmc435の中間体の改善された製造方法

Also Published As

Publication number Publication date
AU2016241924A1 (en) 2017-08-24
CN107429270A (zh) 2017-12-01
EA201792114A1 (ru) 2018-01-31
WO2016157058A1 (fr) 2016-10-06
US20180093943A1 (en) 2018-04-05
MX2017012348A (es) 2017-12-14
KR20170131449A (ko) 2017-11-29
CA2976175A1 (fr) 2016-10-06
JP2018517661A (ja) 2018-07-05
HK1247246A1 (zh) 2018-09-21
EP3274324A1 (fr) 2018-01-31
SG11201707594SA (en) 2017-10-30
BR112017019898A2 (pt) 2018-06-12
IL253899A0 (en) 2017-10-31

Similar Documents

Publication Publication Date Title
EP3507379A4 (fr) Procédés d'amplification numérique du génome entier
MA44884A (fr) Dispositifs et procédés de thrombectomie de l'artère carotide interne
EP3706784A4 (fr) Compositions et procédés de production de lymphocytes t
EP3590942A4 (fr) Inhibiteur d'antigène de surface du virus de l'hépatite b
MA50636A (fr) Compositions et procédés pour inhiber l'activité d'arginase
EP3432926A4 (fr) Procédés de réduction de la toxicité d'un médicament chimiothérapeutique
EP3359693A4 (fr) Procédés et compositions pour enrichissement de produits d'amplification
EP3352774A4 (fr) Compositions de flavonoïdes et procédés d'utilisation
MA46315A (fr) Polythérapies pour malignités hématologiques avec des anticorps anti-cd38 et des inhibiteurs de la survivine
MA45688A (fr) Compositions et procédés de potentialisation d'agents antimicrobiens
IL253999A0 (en) History of tetrahydrothiazepine in cyclics used to treat neoplastic and/or infectious diseases
EP2791342A4 (fr) Microorganismes modifiés et procédés de fabrication du butadiène à l'aide de ceux-ci
EP3504196A4 (fr) Procédés de préparation d'olaparib
MA53445A (fr) Procédés et compositions pour la modification de plantes
EP3294865A4 (fr) Procédés de production d'épimérases et d'alcaloïdes benzylisoquinoléine
EP3289064A4 (fr) Compositions et procédés pour la détection d'allergènes
EP3443094A4 (fr) Procédés de réduction de l'expression de c9orf72
EP3472319A4 (fr) Procédés de conception d'un génome sur la base de règles
EP3328429A4 (fr) Peptides et anticorps pour l'élimination de biofilms
EP3310383A4 (fr) Compositions et procédés d'embolisation virale
EP3632914A4 (fr) Inhibiteur d'antigène de surface du virus de l'hépatite b
EP2967531A4 (fr) Procédés et dispositifs pour la prévention des infections du site opératoire d'incision
EP3488018A4 (fr) Procédés et compositions pour l'identification de protéines
EP3334522A4 (fr) Adsorbants et procédés de fabrication et d'utilisation d'adsorbants
EP3297954A4 (fr) Sorbants pour l'élimination de mercure